Erin Podolak, MA

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

Dr. Marta Salek of St. Jude was in Poland visiting family when Russia invaded Ukraine. She jumped in to help launch the humanitarian effort SAFER Ukraine.

In his laboratory at St. Jude, Stephen Mack, PhD, is researching how metabolic and epigenetic pathways might be perturbed to help treat DIPG, a lethal childhood brain tumor.

Lessons learned from previous global crises inform the St. Jude Global response to childhood cancer patients displaced by the war in Ukraine.

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

Genetic changes in the biology of blood cells can lead them down a path to cancer. This researcher is figuring out how that happens.

G-protein-coupled receptors are a popular target for drug therapies. This researcher is finding out why some drugs targeting GPCRs fail.

Scientist spent more than a decade finding out how this genetic mutation causes different cancers.

Clinical specialists are learning this about the future for childhood cancer survivors and how to help them.

There are new ways to fight diseases fueled by abnormal transcription and gene regulation. Find out more about it during these two symposia.